Picture of Larkberget AB logo

LARK — Larkberget AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Combigene Applies For Patent Protection For Vectors Developed In Lipodystrophy Project CGT2

Aug 25 (Reuters) - Combigene AB  COMBI.ST :
    * COMBIGENE APPLIES FOR PATENT PROTECTION FOR VECTORS
DEVELOPED IN
LIPODYSTROPHY PROJECT CGT2
    * COMBIGENE HAS FILED A PRIORITY PATENT APPLICATION WITH UK
PATENT
OFFICE

Source text: https://bit.ly/32Cc9BN
Further company coverage:  COMBI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Larkberget AB

See all news